scholarly journals Evaluating Metrics Applied to the Medical Science Liaison (MSL) Role: A Survey-Based Study of Canadian MSL Leaders

2021 ◽  
Author(s):  
Munaza Saleem ◽  
Lisa Cesario ◽  
Lisa Wilcox ◽  
Marsha Haynes ◽  
Simon Collin ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Professional ◽  
Online Survey ◽  
Medical Science ◽  
Specialty Care ◽  
Product Lifecycle ◽  
The Past ◽  
Data Analyses ◽  
Quantitative Metrics ◽  
Frequency Of Use

Abstract Introduction Metrics utilized within the Medical Science Liaison (MSL) role are plentiful and traditionally quantitative. We sought to understand the current use and value of metrics applied to the MSL role, including the use of qualitative metrics. Methods We developed a list of 70 MSL leaders working in Canada, spanning 29 companies. Invitations were emailed Jun 16, 2020 and the 25-question online survey was open for 3 weeks. Questions were designed to assess demographics as well as how and why metrics are applied to the MSL role. Data analyses were descriptive. Results Responses were received from 44 leaders (63%). Of the 42 eligible, 45% had ≤ 2 years of experience as MSL leaders and 86% supported specialty care products over many phases of the product lifecycle. A majority (69%) agreed or strongly agreed that metrics are critical to understanding whether an MSL is delivering value, and 98% had used metrics in the past year. The most common reason to use metrics was ‘to show value/impact of MSLs to leadership’ (66%). The most frequently used metric was ‘number of health-care professional (HCP) interactions’, despite this being seen as having moderate value. Quantitative metrics were used more often than qualitative, although qualitative were more often highly valued. Conclusion The data collected show a lack of agreement between the frequency of use for some metrics and their value in demonstrating the contribution of an MSL. Overall, MSL leaders in our study felt qualitative metrics were a better means of showing the true impact of MSLs.

scholarly journals Drug Use Changes at the Individual Level: Results from a Longitudinal, Multisite Survey in Young Europeans Frequenting the Nightlife Scene

2021 ◽  
pp. 1-6
Author(s):  
Meryem Grabski ◽  
Jon Waldron ◽  
Tom P. Freeman ◽  
Claire Mokrysz ◽  
Ruben J.J. van Beek ◽  
...  
Keyword(s):  
Drug Use ◽  
Online Survey ◽  
Prescription Opioids ◽  
Alkyl Nitrates ◽  
Cross Sectional ◽  
Individual Level ◽  
The Past ◽  
Frequency Of Use ◽  
The Individual

<b><i>Background:</i></b> Monitoring emerging trends in the increasingly dynamic European drug market is vital; however, information on change at the individual level is scarce. In the current study, we investigated changes in drug use over 12 months in European nightlife attendees. <b><i>Method:</i></b> In this longitudinal online survey, changes in substances used, use frequency in continued users, and relative initiation of use at follow-up were assessed for 20 different substances. To take part, participants had to be aged 18–34 years; be from Belgium, Italy, the Netherlands, Sweden, or the UK; and have attended at least 6 electronic music events in the past 12 months at baseline. Of 8,045 volunteers at baseline, 2,897 completed the survey at both time points (36% follow-up rate), in 2017 and 2018. <b><i>Results:</i></b> The number of people using ketamine increased by 21% (<i>p</i> &#x3c; 0.001), and logarithmized frequency of use in those continuing use increased by 15% (<i>p</i> &#x3c; 0.001; 95% CI: 0.07–0.23). 4-Fluoroamphetamine use decreased by 27% (<i>p</i> &#x3c; 0.001), and logarithmized frequency of use in continuing users decreased by 15% (<i>p</i> &#x3c; 0.001, 95% CI: −0.48 to −0.23). The drugs with the greatest proportion of relative initiation at follow-up were synthetic cannabinoids (73%, <i>N</i> = 30), mephedrone (44%, <i>N</i> = 18), alkyl nitrites (42%, <i>N</i> = 147), synthetic dissociatives (41%, <i>N</i> = 15), and prescription opioids (40%, <i>N</i> = 48). <b><i>Conclusions:</i></b> In this European nightlife sample, ketamine was found to have the biggest increase in the past 12 months, which occurred alongside an increase in frequency of use in continuing users. The patterns of uptake and discontinuation of alkyl nitrates, novel psychoactive substances, and prescription opioids provide new information that has not been captured by existing cross-sectional surveys. These findings demonstrate the importance of longitudinal assessments of drug use and highlight the dynamic nature of the European drug landscape.

scholarly journals Effect of Health Care Providers’ Focused Discussion and Proactive Education About Relapse Management on Patient Reporting of Multiple Sclerosis Relapse

2021 ◽  
Author(s):  
Royce W. Waltrip ◽  
Nancy Mahler ◽  
Alina Ahsan ◽  
Leslie B. Herbert
Keyword(s):  
Multiple Sclerosis ◽  
Health Care ◽  
Health Care Providers ◽  
Online Survey ◽  
Care Providers ◽  
Patient Reporting ◽  
Multiple Sclerosis Relapse ◽  
The Past ◽  
Disease Modifying Therapy

Abstract Background: Treatments for multiple sclerosis (MS) relapse include intravenous corticosteroids and repository corticotropin injection. Despite available treatment, in the Multiple Sclerosis in America 2017 survey, only 47% of patients reported always/often contacting their MS health care provider (HCP) during relapse. In this study, the Multiple Sclerosis in America 2017 survey participants who received intravenous corticosteroids or repository corticotropin injection for treatment of past relapses completed a follow-up survey to understand how patients characterize relapse severity and to explore predictors of patients contacting their HCP during a relapse. Methods: Patients were18 years and older, diagnosed as having MS by an HCP, and currently using disease-modifying therapy. Patients completed an online survey assessing relapse characteristics and interactions with the HCP treating the patient’s MS. Regression analysis identified predictors of patients contacting their HCP during relapse. Results: Mean age of the 126 respondents was 49.2 years, 81.0% were female, and most (80.2%) had one or more relapses in the past 2 years. Patients estimated that 38.3% of their relapses were mild; 45.1%, moderate; and 16.6%, severe. Number and frequency of symptoms increased with relapse severity. Less than half (46.0%) reported they were extremely likely to contact their HCP during a relapse. The best predictors of being likely to contact the HCP during relapse were the HCP having previously discussed the importance of immediately communicating a relapse and patients’ willingness to accept the HCP’s recommendation for relapse treatment. Conclusions: Findings highlight the importance of HCPs’ advance discussions with patients with MS regarding relapse management to increase the likelihood patients will contact their HCP during relapse.

Young Stroke Survivors' Preferred Methods of Meeting Their Unique Needs

Neurology ◽  
2021 ◽  
Vol 96 (13) ◽  
pp. e1701-e1710
Author(s):  
Jessica Keating ◽  
Karen Borschmann ◽  
Hannah Johns ◽  
Leonid Churilov ◽  
Julie Bernhardt
Keyword(s):  
Health Care ◽  
Health Care Professional ◽  
Online Survey ◽  
Care Setting ◽  
Alternative Methods ◽  
Stroke Survivors ◽  
Face To Face ◽  
Young Stroke ◽  
Traditional Health ◽  
Traditional Health Care

ObjectiveTo determine how young stroke survivors want their unmet needs to be addressed, we undertook an international online survey of people living with stroke.MethodsParticipants self-selected to complete an online survey that included a questionnaire on demographics and stroke-related characteristics, the Young Stroke Needs Screening Tool, and a questionnaire on how they wanted their needs to be met.ResultsOne hundred seventy-one responses were received (68% female respondents, mean age 45 years, interquartile range 36–51 years). Preferences for methods of meeting needs varied depending on the domain of need and participants' demographic and stroke-related characteristics. Face-to-face contact with a health care professional was a popular means of meeting needs, but methods outside of a traditional health care setting such as a succinct list of tips or peer support were widely acceptable and sometimes preferred.ConclusionThis work provides the impetus for developing alternative methods of meeting young stroke survivors' needs, many of which are not resource intensive or do not require an appointment with a health care professional.

GENESIS OF FORMATION AND DEVELOPMENT OF PUBLIC ADMINISTRATION IN THE FIELD OF TRANSPLANTOLOGY IN UKRAINE

2018 ◽  
Author(s):  
Viktoriya Kykot ◽  
Keyword(s):  
Health Care ◽  
Public Relations ◽  
Public Administration ◽  
Preventive Medicine ◽  
Medical Science ◽  
The Past ◽  
History Of ◽  
Rich History ◽  
Independent Branch ◽  
Country Today

The article considers the issues of formation and development of the field of transplantology in Ukraine, scientists who discovered, developed, glorified this field in the country. It has been established that the field of transplantation is an important component of the sphere of health care, and is also a particularly important task of state activity in general, which is to ensure public relations in the field under study. It has been studied that transplantation as a method of treatment is shown in a large number of different diseases, it is often the only way to save lives, and its history is inextricably linked with the development of medicine as a whole. Ukrainian medical science has a rich history associated with the names of prominent scientists in the field of theoretical, clinical and preventive medicine of the past and present. The proposal to cover the history of transplantology as one of the branches of medical science, which is an independent branch of health care, and in general the general history of human culture, which considers the development of knowledge related to diseases, human treatment, preservation and promotion of health. and the task of the whole country today is to help the development of this industry for the sake of new lives saved, for the sake of the future.

scholarly journals CONFIDENCE IN HEALTH INSURANCE AFFORDABILITY AND DELAYED OR FORGONE HEALTH CARE AMONG ADULTS APPROACHING RETIREMENT

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S12-S12
Author(s):  
Jamie Luster ◽  
Renuka Tipirneni ◽  
Erica Solway ◽  
Preeti Malani ◽  
Jeffrey Kullgren ◽  
...  
Keyword(s):  
Health Care ◽  
Decision Making ◽  
Health Insurance ◽  
Medical Care ◽  
Online Survey ◽  
Retirement Age ◽  
The Past

Abstract Recent challenges to the ACA may add uncertainties to decision-making about health insurance. We sought to determine if health insurance affordability concerns were associated with delayed/forgone health care among adults approaching retirement age. In October 2018, the NPHA conducted an online survey of US adults age 50-64. 45% of respondents had little/no confidence in ability to afford health insurance when they retire, and 27% little/no confidence in this over the next year. In the past year, 13% had not gotten medical care and 12% had not filled a prescription because of cost concerns. Controlling for demographic and health characteristics, having little/no confidence in health insurance affordability in retirement/within the next year was associated with delaying/forgoing health care (aOR 2.80, p&lt;0.001). Despite the ACA’s coverage expansions and consumer protections, these findings suggest adults worry about the affordability of health insurance in retirement and may avoid needed health care for that reason.

scholarly journals Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada

2019 ◽  
Vol 26 (4) ◽  
Author(s):  
P. Hawley ◽  
M. Gobbo
Keyword(s):  
Health Care ◽  
Adverse Effects ◽  
Cancer Patients ◽  
Health Care Professional ◽  
Cannabis Use ◽  
Routes Of Administration ◽  
The Past ◽  
Current State ◽  
Patients Experience ◽  
Multiple Symptoms

Background Cancer patients experience multiple symptoms throughout their illness, and some report benefit from the use of cannabis. There are concerns that many patients are accessing products inappropriate for their situation and potentially putting themselves at risk. In the present study, we aimed to capture the prevalence of cannabis use among cancer patients at BC Cancer before recreational legalization in Canada and to identify the reasons that patients take cannabis, the various routes of administration they use, and the reasons that prior users stopped.Methods Patients were eligible if, on the selected study day (15 August 2018), they were scheduled for an appointment at any of the 6 BC Cancer sites. Eligible patients were mailed a survey.Results Of surveys sent to 2998 patients, 821 (27.4%) were returned and included in analysis. Of those respondents, 23% were currently using cannabis-based products, almost exclusively for medical purposes, and an additional 28% had been users in the past (most often recreationally). Of the patients currently using cannabis, 31% had medical authorization. The most common symptoms that the current users were targeting were pain, insomnia, nausea, and anxiety; many were also hoping for anticancer effects.Conclusions More than half the respondents had tried cannabis at some time, and almost one quarter of respondents were currently taking cannabis to help manage their symptoms or treat their cancer, or both. Many more patients would consider use with appropriate guidance from a health care professional. More research is needed to inform physicians and patients about safe uses and doses and about the potential adverse effects of cannabis use.

Cosmeceuticals

2016 ◽  
pp. 287-308 ◽  
Author(s):  
Long Chiau Ming ◽  
Wei Chern Ang ◽  
Quan Yang ◽  
Premrutai Thitilertdecha ◽  
Tin Wui Wong ◽  
...  
Keyword(s):  
Health Care ◽  
Research And Development ◽  
Health Care Professional ◽  
Evidence Based ◽  
Bleaching Agent ◽  
The Past ◽  
Key Players ◽  
Sale Volume ◽  
Provide Health Care

Cosmeceuticals are topical cosmetic-pharmaceutical hybrids used to maintain and improve appearance and beauty of the skin. The strong demand from the consumers to constantly look youthful and flawless has driven the research and development as well as sale volume of cosmeceuticals. Present studies show that many cosmetic products, which were assumed to be inert in the past, may modulate dermatological structure or function. The key players of cosmeceuticals are anti-aging therapy along with bleaching agent, sunscreen, and hair cosmeceuticals. This book chapter aims to explore the safety, toxicity and efficacy of these cosmeceuticals. Challenges and possible advancement potentials would be discussed. As patients are increasingly seeking advice from physicians and pharmacists regarding cosmeceuticals, the authors hope to provide health care professional and pharmaceutical scientists a resource that would aid to educate patients in using evidence-based cosmeceuticals to enhance their appearance and alleviate dermatological problems.

Sign in / Sign up

Export Citation Format

Share Document